https://orcid.org/0000-0001-7810-5214
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi & Abbas Al Mutair. (2022) COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Amanda Izeli Portilho, Victor Araujo Correa, Cinthya dos Santos Cirqueira & Elizabeth De Gaspari. (2022) Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory. Immunological Investigations 51:7, pages 2066-2085.
Read now
Read now
Articles from other publishers (21)
Bingjie Ma, Mengxiao Tao, Zhili Li, Quanfang Zheng, Haigang Wu & Peirong Chen. (2024) Mucosal vaccines for viral diseases: Status and prospects. Virology 593, pages 110026.
Crossref
Crossref
Yufeng Song, Frances Mehl & Steven L. Zeichner. (2024) Vaccine Strategies to Elicit Mucosal Immunity. Vaccines 12:2, pages 191.
Crossref
Crossref
Leila Sadeghi, Elham Mohit, Samaneh Moallemi, Fatemeh Maghsood Ahmadi & Azam Bolhassani. (2023) Recent advances in various bio-applications of bacteria-derived outer membrane vesicles. Microbial Pathogenesis 185, pages 106440.
Crossref
Crossref
Chuyu Li, Chenguang Wang, Hai‐Yan Xie & Lili Huang. (2023) Cell‐Based Biomaterials for Coronavirus Disease 2019 Prevention and Therapy. Advanced Healthcare Materials 12:18.
Crossref
Crossref
Himadri B. Thapa, Stephan P. Ebenberger & Stefan Schild. (2023) The Two Faces of Bacterial Membrane Vesicles: Pathophysiological Roles and Therapeutic Opportunities. Antibiotics 12:6, pages 1045.
Crossref
Crossref
Amanda Izeli Portilho & Elizabeth De Gaspari. 2023. COVID-19 Vaccines - Current State and Perspectives. COVID-19 Vaccines - Current State and Perspectives.
Hernan H. M. da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro N. Duarte-Neto, Cinthya S. Cirqueira, Rodrigo A. Réssio, Cristina T. Kanamura, Karen Miguita, Jerenice E. Ferreira, Raimunda T. M. Santos, Patricia P. Adriani, Jair P. Cunha-Junior, Renato M. Astray, Regina M. Catarino, Marcelo Lancelotti & Carlos R. Prudencio. (2023) RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2. Viruses 15:2, pages 555.
Crossref
Crossref
Sagar S. Arya, Nada K. Morsy, Deema K. Islayem, Sarah A. Alkhatib, Charalampos Pitsalidis & Anna-Maria Pappa. (2023) Bacterial Membrane Mimetics: From Biosensing to Disease Prevention and Treatment. Biosensors 13:2, pages 189.
Crossref
Crossref
Vladimir P. Baklaushev, Gaukhar M. Yusubalieva, Mikhail V. Bychinin, Saule M. Yusubalieva, Vladimir A. Kalsin & Aleksandr V. Troitskiy. (2022) A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains. Journal of Clinical Practice 13:3, pages 43-55.
Crossref
Crossref
Gabrielle Gimenes Lima, Amanda Izeli Portilho & Elizabeth De Gaspari. (2022) Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal–fetal transference of antibodies in mice. Pathogens and Disease 80:1.
Crossref
Crossref
Victor Araujo Correa, Amanda Izeli Portilho & Elizabeth De Gaspari. (2022) Vaccines, adjuvants and key factors for mucosal immune response. Immunology 167:2, pages 124-138.
Crossref
Crossref
Dharmendra Kashyap, Mrutyunjaya Panda, Budhadev Baral, Nidhi Varshney, Sajitha R, Vasundhra Bhandari, Hamendra Singh Parmar, Amit Prasad & Hem Chandra Jha. (2022) Outer Membrane Vesicles: An Emerging Vaccine Platform. Vaccines 10:10, pages 1578.
Crossref
Crossref
Puthupparampil V. Scaria, Chris G. Rowe, Beth B. Chen, Thayne H. Dickey, Jonathan P. Renn, Lynn E. Lambert, Emma K. Barnafo, Kelly M. Rausch, Niraj H. Tolia & Patrick E. Duffy. (2022) Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines. iScience 25:8, pages 104739.
Crossref
Crossref
Nishta Krishnan, Luke J. Kubiatowicz, Maya Holay, Jiarong Zhou, Ronnie H. Fang & Liangfang Zhang. (2022) Bacterial membrane vesicles for vaccine applications. Advanced Drug Delivery Reviews 185, pages 114294.
Crossref
Crossref
Stephanie M. Curley & David Putnam. (2022) Biological Nanoparticles in Vaccine Development. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Sujit K. Debnath & Rohit Srivastava. (2022) Potential Application of Bionanoparticles to Treat Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Frontiers in Nanotechnology 3.
Crossref
Crossref
Amanda Izeli Portilho, Gabrielle Gimenes Lima & Elizabeth De Gaspari. (2022) SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity. Clinics 77, pages 100057.
Crossref
Crossref
Amanda Izeli Portilho, Victor Araujo Correa, Emanuelle Baldo Gaspar & Elizabeth De Gaspari. 2022. Frontiers of COVID-19. Frontiers of COVID-19
539
559
.
Ahmed A. Al-Karmalawy, Raya Soltane, Ayman Abo Elmaaty, Mohamed A. Tantawy, Samar A. Antar, Galal Yahya, Amani Chrouda, Rami Adel Pashameah, Muhamad Mustafa, Mobarak Abu Mraheil & Ahmed Mostafa. (2021) Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview. Vaccines 9:11, pages 1317.
Crossref
Crossref
Christiane Chbib, Sarthak M. Shah, Rikhav P. Gala & Mohammad N. Uddin. (2021) Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis. Vaccines 9:11, pages 1245.
Crossref
Crossref
Andrew D. Moura, Hernan H. M. da Costa, Victor A. Correa, Ana K. de S. Lima, José A. L. Lindoso, Elizabeth De Gaspari, Marisa A. Hong, Jair P. Cunha-Junior & Carlos R. Prudencio. (2021) Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients. Scientific Reports 11:1.
Crossref
Crossref